ClassID:

20918

A61K38/1709 - page 18 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#5101
20070087035
2007-04-19

Nutritional composition for wound healing

#5102
20070086991
2007-04-19

Use of strains of lactobacillus and by-products thereof for inhibiting formation of blood vessels

#5103
20070085059
2007-04-19

Bioactive complexes compositions and methods of use thereof

#5104
20070082371
2007-04-12

FAMILY OF GENES ENCODING APOPTOSIS-RELATED PEPTIDES, PEPTIDES ENCODED THEREBY AND METHODS OF USE THEREOF

#5105
20070082335
2007-04-12

Method for reducing HIV viral budding by administering a VPS28-specfic antibody that disrupts Gag-TSG101-VPS28 binding interactions

#5106
20070081978
2007-04-12

Adeno-associated virus-mediated survivin mutants and methods related thereto

#5107
20070078259
2007-04-05

Uses of human Zven proteins and polynucleotides

#5108
20070077574
2007-04-05

Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof

#5109
20070077545
2007-04-05

Sperm protective polypeptides and uses thereof

#5110
20070072822
2007-03-29

STAT3 agonists and antagonists and therapeutic uses thereof

#5111
20070072798
2007-03-29

Method for treatment of cardiovascular and metabolic diseases and detecting the risk of the same

#5112
20070072224
2007-03-29

Diagnosis and treatment of tumor-suppressor associated disorders

#5113
20070072217
2007-03-29

XAF genes and polypeptides: methods and reagents for modulating apoptosis

#5114
20070071828
2007-03-29

Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment

#5115
20070071751
2007-03-29

FAMILY OF GENES ENCODING APOPTOSIS-RELATED PEPTIDES, PEPTIDES ENCODED THEREBY AND METHODS OF USE THEREOF

#5116
20070071740
2007-03-29

Purified amniotic membrane compositions and methods of use

#5117
20070066803
2007-03-22

Method to control tumor progression and invasiveness

#5118
20070066518
2007-03-22

Pharmaceutical composition for inducing apoptosis comprising a fusion protein between bfl-1 and green fluorescent protein or a gene encoding same

#5119
20070065908
2007-03-22

Human cathelicidin antimicrobial peptides

#5120
20070065506
2007-03-22

Nutraceutical composition comprising soluble keratin or derivative thereof

#5121
20070065433
2007-03-22

Methods and compositions for the treatment of meconium aspiration syndrome

#5122
20070065427
2007-03-22

Agents that modulate the interaction of B7-1 polypeptide with PD-L1 and methods of use thereof

#5123
20070065421
2007-03-22

Inducing expression of puma to reduce joint inflammation in the treatment of arthritis

#5124
20070065405
2007-03-22

Uses of human Zven proteins and polynucleotides

#5125
20070065404
2007-03-22

Uses of humans zven proteins and polynucleotides

#5126
20070065403
2007-03-22

Uses of human Zven proteins and polynucleotides

#5127
20070065399
2007-03-22

Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules

#5128
20070065368
2007-03-22

Compositions and methods for suppressing fibrocytes and for detecting fibrocyte differentiation

#5129
20070060521
2007-03-15

Inhibition of STAT3 signal transduction for human cancer therapy

#5130
20070060519
2007-03-15

Hsp therapy in conjunction with a low antigenicity diet

#5131
20070060516
2007-03-15

Chimeric peptides comprising HER-2 B-cell epitopes and measles virus fusion protein T-cell epitopes

#5132
20070059794
2007-03-15

Chaperonin-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure of target protein, sustained-release formulation, and method of producing antibody against target protein

#5133
20070059691
2007-03-15

Method for determining the susceptibility of a subject to infection

#5134
20070059684
2007-03-15

Method of identifying an antiviral agent

#5135
20070059294
2007-03-15

Therapeutiv preparation for hematopoietic disease

#5136
20070059289
2007-03-15

Methods of improving cardiac function and attenuating and/or preventing cardiac remodeling with Hsp20

#5137
20070054855
2007-03-08

Modified annexin compositions and methods of using same

#5138
20070054848
2007-03-08

Composition and method for nerve regeneration

#5139
20070053934
2007-03-08

Polyvalent multimeric composition containing active polypeptides, pharmaceutical compositions and methods of using the same

#5140
20070053921
2007-03-08

Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer

#5141
20070053908
2007-03-08

USES OF HUMAN ZVEN ANTAGONISTS

#5142
20070053907
2007-03-08

USES OF HUMAN ZVEN ANTAGONISTS

#5143
20070050856
2007-03-01

Use of protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome

#5144
20070049526
2007-03-01

Methods of modulating gastrointestinal contractility

#5145
20070048778
2007-03-01

Methods of detecting or diagnosing inflammatory bowel disease using prokineticin polynucleotides

#5146
20070048286
2007-03-01

Method of treating dopaminergic and GABA-nergic disorders

#5147
20070048258
2007-03-01

Use of human Zven proteins and polynucleotides

#5148
20070042949
2007-02-22

Pharmaceutical compositions comprising an epitope of platelet gpiiia protein

#5149
20070042948
2007-02-22

Vav inhibition in graft rejection

#5150
20070042947
2007-02-22

Agents for preventing and/or treating uppper digestive tract disorders

#5151
20070042941
2007-02-22

Galectin 9-inducing factors

#5152
20070042347
2007-02-22

High throughput biological heart rate monitor that is molecularly determined

#5153
20070041957
2007-02-22

Stimulation of cellular regeneration and differentiation in the inner ear

#5154
20070041945
2007-02-22

NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID

#5155
20070041942
2007-02-22

Use of calcium binding proteins to improve cardiac contractile function

#5156
20070037744
2007-02-15

Human cathelicidin antimicrobial peptides

#5157
20070037739
2007-02-15

Compounds useful in coating stents to prevent and treat stenosis and restenosis

#5158
20070037736
2007-02-15

Therapeutic composition comprising the KAL protein and use of the KAL protein for the treatment of retinal, renal, neuronal and neural injury

#5159
20070037210
2007-02-15

Cytokine receptor modulators and method of modulating cytokine receptor activity

#5160
20070036812
2007-02-15

HLA-A24 binding cancer antigen peptide derived from livin

#5161
20070036810
2007-02-15

Cyclic amp response element activator proteins and uses related thereto

#5162
20070036761
2007-02-15

Lentiviral apoe2 gene therapy

#5163
20070032426
2007-02-08

Therapeutic and diagnostic methods for ulcerative colitis and associated disorders

#5164
20070031965
2007-02-08

Anti-pathogen treatments

#5165
20070031899
2007-02-08

Pharmaceutical agents

#5166
20070031403
2007-02-08

Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use

#5167
20070031396
2007-02-08

Method of treating neurological diseases

#5168
20070031384
2007-02-08

Regeneration of pancreatic islets by amniotic fluid stem cell therapy

#5169
20070027169
2007-02-01

XIAP-targeted prostate cancer therapy

#5170
20070027081
2007-02-01

Method for inducing deposition and maturation of bone comprising a co-therapeutic regimen of LMP-1 and BMP-2

#5171
20070026441
2007-02-01

Methods for reducing viral load in HIV-1-infected patients

#5172
20070025998
2007-02-01

METHODS FOR ENHANCING THE EFFICACY OF CANCER THERAPY

#5173
20070025984
2007-02-01

Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms

#5174
20070025915
2007-02-01

Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith

#5175
20070021337
2007-01-25

Novel agent for inducing apoptosis comprising Msx1 or a gene encoding the same as an active ingredient

#5176
20070020673
2007-01-25

Model of autoimmune disease and methods for identifying agents against autoimmune disease

#5177
20070020251
2007-01-25

Paralytic peptide for use in neuromuscular therapy

#5178
20070015705
2007-01-18

Modified annexin compositions and methods of using same

#5179
20070014768
2007-01-18

Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms

#5180
20070014766
2007-01-18

Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof

#5181
20070014764
2007-01-18

Reduction in myocardial infarction size

#5182
20070014742
2007-01-18

INTEGRIN BINDING MOTIF CONTAINING PEPTIDES AND METHODS OF TREATING SKELETAL DISEASES

#5183
20070010483
2007-01-11

Glucocerebroside treatment of liver disorders

#5184
20070010468
2007-01-11

Methods and compositions for the inhibition of stat5 in prostate cancer cells

#5185
20070010435
2007-01-11

Method for treating amyloid disease

#5186
20070009926
2007-01-11

Biomarkers of resistance to infections in humans and biological applications thereof

#5187
20070009918
2007-01-11

Methods and compositions for regulating T cell subsets by modulating transcription factor activity

#5188
20070009575
2007-01-11

Novel use of antisecretory factor

#5189
20070009543
2007-01-11

Protein involved in ovarian cancer

#5190
20070004658
2007-01-04

Method and means for treatment of osteoarthritis

#5191
20070004628
2007-01-04

Compositions and methods for nerve regeneration

#5192
20070004621
2007-01-04

Bex4 nucleic acids, polypeptides, and method of using

#5193
20070004618
2007-01-04

Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin

#5194
20070004617
2007-01-04

Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments

#5195
20070003543
2007-01-04

Low dose histone peptide treatment for autoimmune disorders

#5196
20060293240
2006-12-28

Human Sef isoforms and methods of using same for cancer diagnosis and gene therapy

#5197
20060293239
2006-12-28

Treatment and Diagnosis of Insulin-Resistant States

#5198
20060293225
2006-12-28

Gmg-2 polynucleotides and polypeptides and uses thereof

#5199
20060287227
2006-12-21

Methods of inhibiting secretion of follicle-stimulating hormone and testosterone

#5200
20060286075
2006-12-21

Method and compositions for treating hepatocellular cancer

#5201
20060281821
2006-12-14

Retinoid replacements and opsin agonists and methods for the use thereof

#5202
20060281681
2006-12-14

Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease

#5203
20060281680
2006-12-14

Methods and compositions for modulating vascular integrity

#5204
20060281674
2006-12-14

S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment

#5205
20060281179
2006-12-14

Inducer for differentiation of embryo stem cells into ectodermal cells method of obtaining the same and use thereof

#5206
20060280802
2006-12-14

Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2

#5207
20060276391
2006-12-07

Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization

#5208
20060276389
2006-12-07

Fugetactic proteins, compositions and methods of use

#5209
20060276388
2006-12-07

Hip/pap polypeptide compositions for use in liver regeneration and for the prevention of liver failure

#5210
20060276386
2006-12-07

Use of substances inhibiting the association of said protein with ubiquitin c-terminal hydrolase for altering cellular responses to tgf-beta or bmp

#5211
20060276385
2006-12-07

Anti-inflammatory agents and methods of their use

#5212
20060276376
2006-12-07

Increasing functional glycosylation of alpha-dystroglycan in the treatment of muscle degeneration

#5213
20060276374
2006-12-07

Use of an agent that restores tissue perfusion and oxygenation

#5214
20060275295
2006-12-07

Activity of THAP-family chemokine-binding domains

#5215
20060270699
2006-11-30

Stabilization of hypoxia inducible factor (HIF) alpha

#5216
20060270597
2006-11-30

Compositions of THAP-family chemokine binding domains

#5217
20060270596
2006-11-30

Compositions of THAP-family chemokine binding domains

#5218
20060270592
2006-11-30

Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions

#5219
20060264380
2006-11-23

Compounds and Methods for Promoting Angiogenesis

#5220
20060264377
2006-11-23

Chemically modified novel erythropoietin stimulating protein compositions and methods

#5221
20060263835
2006-11-23

Identification of agonistic autoantibodies

#5222
20060263422
2006-11-23

Pharmaceutical composition containing decoy and use of the same

#5223
20060263348
2006-11-23

Apolipoprotein L-I and/or derivated polypeptide for the treatment of and/or the prevention of diseases induced by

#5224
20060258702
2006-11-16

Stabilization of hypoxia inducible factor (HIF) alpha

#5225
20060258660
2006-11-16

Stabilization of hypoxia inducible factor (HIF) alpha

#5226
20060258591
2006-11-16

Compositions and methods of treating HIV infections

#5227
20060258570
2006-11-16

Decorin proteoglycan inhibitor of fibrinogen blood clotting

#5228
20060252716
2006-11-09

Method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia"

#5229
20060252694
2006-11-09

Multimeric apoprotein agonists

#5230
20060252692
2006-11-09

Inhibitors for use in hemostasis

#5231
20060252677
2006-11-09

Postsynaptic proteins

#5232
20060251627
2006-11-09

Targeted vectors for cancer immunotherapy

#5233
20060247252
2006-11-02

Augmented cognitive training

#5234
20060247160
2006-11-02

Metabolic gene polynucleotides and polypeptides and uses thereof

#5235
20060247153
2006-11-02

Method of improving learning and memory in mammals

#5236
20060246543
2006-11-02

Slim compositions and methods of use thereof

#5237
20060246505
2006-11-02

Modulation of the synthesis of insulin

#5238
20060246146
2006-11-02

Method of increasing the salivary sialic acid content in a mammal

#5239
20060246037
2006-11-02

Neuroprotective effects of atf6

#5240
20060241066
2006-10-26

Decoy composition for treating and preventing inflammatory disease

#5241
20060241038
2006-10-26

Therapeutic agent for Abeta related disorders

#5242
20060241035
2006-10-26

Use of dg153 secreted protein products for preventing and treating pancreatic disease and/or obesity and/or metabolic syndrome

#5243
20060240494
2006-10-26

Biocidal molecules, macromolecular targets and methods of production and use

#5244
20060240016
2006-10-26

Activity of THAP-family chemokine-binding domains

#5245
20060239988
2006-10-26

Neuronal regeneration and compound administration methods

#5246
20060239975
2006-10-26

Methods for treating cancers and restenosis with p21

#5247
20060239969
2006-10-26

Rhesus HER2/neu, nucleotides encoding same, and uses thereof

#5248
20060239965
2006-10-26

Extracellular matrix binding chimeric proteins and methods of use thereof

#5249
20060234930
2006-10-19

Use of dg008,dg065,dg210 or dg239 secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome

#5250
20060234929
2006-10-19

RasGAP derived peptide for selectively killing cancer cells

#5251
20060234925
2006-10-19

Embryo implantation inhibitor

#5252
20060234908
2006-10-19

Methods for improving the structure and function of arterioles

#5253
20060233799
2006-10-19

Use of IL-18BP for treatment of peripheral vascular diseases

#5254
20060229241
2006-10-12

Hypoxia induced mitogenic factor

#5255
20060228416
2006-10-12

Methods for modulating topical inflammatory response

#5256
20060228392
2006-10-12

NELL-1 enhanced bone mineralization

#5257
20060228299
2006-10-12

Constructs binding to phosphatidylserine and their use in disease treatment

#5258
20060223121
2006-10-05

Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease

#5259
20060222637
2006-10-05

Methods for stimulating or enhancing proliferation of non-tumorous cells expressing MUC1 receptors

#5260
20060222635
2006-10-05

Methods and compositions for selecting cells with increased potency

#5261
20060217312
2006-09-28

Charged lipoprotein complexes and their uses

#5262
20060217307
2006-09-28

Methods for regulating inflammatory mediators and peptides useful therein

#5263
20060217306
2006-09-28

Systemic treatment of infections with defensins

#5264
20060217296
2006-09-28

Use of ghrelin for treating malnutrition in gastrectomized individuals

#5265
20060216330
2006-09-28

Peptides having an ace inhibiting effect

#5266
20060216295
2006-09-28

Methods of identifying therapeutic targets for the treatment of vulvovaginal atrophy

#5267
20060216262
2006-09-28

METHOD OF TREATING SKIN USING COMPOSITION INCLUDING CHAPERONIN PROTEINS

#5268
20060211614
2006-09-21

Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit 1

#5269
20060211609
2006-09-21

Novel agent for improving neurotransmission failure

#5270
20060211602
2006-09-21

Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors

#5271
20060211600
2006-09-21

Stem cell-derived factors for treating pathologic conditions

#5272
20060211015
2006-09-21

Novel compositions and methods for cancer

#5273
20060210493
2006-09-21

Dental products comprising bone growth enhancing peptide

#5274
20060206949
2006-09-14

Custom-made meganuclease and use thereof

#5275
20060205646
2006-09-14

Methods for increasing cell and tissue viability

#5276
20060205645
2006-09-14

Hypoxia inducible factor 2α for curing neonatal respiratory distress syndrome and as a target for the treatment of pulmonary hypertension

#5277
20060205008
2006-09-14

Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis

#5278
20060199946
2006-09-07

Apoptosis inducing agent and method for inducing apoptosis

#5279
20060199769
2006-09-07

Alpha-fetoprotein peptides and uses thereof

#5280
20060198839
2006-09-07

Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions

#5281
20060198834
2006-09-07

Chaperonin 10 immunosuppression

#5282
20060194740
2006-08-31

NOD1 as an anti-tumor agent

#5283
20060194732
2006-08-31

Recombinant SP-A for the treatment or prevention of pulmonary infection and inflammation

#5284
20060193920
2006-08-31

Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors

#5285
20060193864
2006-08-31

Conversion of apoptotic proteins

#5286
20060193828
2006-08-31

Method for treating myeloma utilizing an expression enhancer for HM1.24 antigen

#5287
20060189563
2006-08-24

Detection and modulation of IAPS and NAIP for the diagnosis and treatment of proliferative disease

#5288
20060189530
2006-08-24

Neuropeptide Y receptor Y5 and nucleic acid sequences

#5289
20060189526
2006-08-24

COMPOSITIONS CONTAINING AN INTESTINAL TREFOIL PEPTIDE AND A MUCOADHESIVE

#5290
20060189518
2006-08-24

Preventing/remedies for cancer

#5291
20060188480
2006-08-24

Viral vectors

#5292
20060188473
2006-08-24

Methods for repressing B cell autoantibody secretion and for treating autoimmune disorders by administration of hematopoietic stem cells and macrophage-colony stimulating factor

#5293
20060183695
2006-08-17

Methods of increasing endogenous erythropoietin (EPO)

#5294
20060183671
2006-08-17

Treatment of anemia

#5295
20060183130
2006-08-17

Methods for assessing p19-Arf interactions in cMyc

#5296
20060182749
2006-08-17

Therapies for cancer using RLIP76

#5297
20060178317
2006-08-10

Methods of increasing endogenous erythropoietin (EPO)

#5298
20060178316
2006-08-10

Methods of increasing endogenous erythropoietin (EPO)

#5299
20060178307
2006-08-10

Modulation of NMDA receptor currents via orexin receptor and/or CRF receptor

#5300
20060178306
2006-08-10

Modulation of the neuroendoctrine system as a therapy for motor neuron disease

#5301
20060178295
2006-08-10

Steroid conjugates, preparation thereof and the use thereof

#5302
20060177514
2006-08-10

Preparation of a therapeutic composition

#5303
20060172945
2006-08-03

Human neutrophil alpha-defensin 4 inhibition of HIV-1

#5304
20060172943
2006-08-03

Restoring vascular function

#5305
20060172940
2006-08-03

Antimicrobial agent

#5306
20060172939
2006-08-03

Methods and apparatus for creating particle derivatives of HDL with reduced lipid content

#5307
20060172360
2006-08-03

MKK7 activation inhibitor

#5308
20060172304
2006-08-03

Method for modulating epithelial stem cell lineage

#5309
20060171920
2006-08-03

Reversible pegylated drugs

#5310
20060166941
2006-07-27

Treatment and/or prevention of non-viral epithelial damage

#5311
20060166880
2006-07-27

Control of function of intracellular Ca ion

#5312
20060166864
2006-07-27

Methods for modulating telomerase activity

#5313
20060166860
2006-07-27

Zinc transporter compositions for the treatment of cardiovascular diseases

#5314
20060166220
2006-07-27

Chimeric tumor suppressor gene and protein

#5315
20060165773
2006-07-27

Gene therapy of tumors using non-viral delivery system

#5316
20060165710
2006-07-27

Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes

#5317
20060165689
2006-07-27

Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7

#5318
20060165651
2006-07-27

Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof

#5319
20060160733
2006-07-20

Compositions and methods for treating and preventing heart tissue degeneration and uses thereof

#5320
20060160214
2006-07-20

Engineered intervertebral disc tissue

#5321
20060160142
2006-07-20

Phosophoinositoglycan binding proteins

#5322
20060159770
2006-07-20

Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus

#5323
20060159692
2006-07-20

Transcriptional factor inducing apoptosis in cancer cell

#5324
20060159665
2006-07-20

Seed tear resistant scaffold

#5325
20060159663
2006-07-20

Growth factor encapsulation system for enhancing bone formation

#5326
20060159652
2006-07-20

GD2 ligands

#5327
20060159623
2006-07-20

Stem cells for use in locating and targeting tumor cells

#5328
20060153826
2006-07-13

Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof

#5329
20060153808
2006-07-13

Cancer immunotherapy incorporating p53

#5330
20060149050
2006-07-06

Isolation and method of using tissue growth-inducing Frzb

#5331
20060148813
2006-07-06

Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit

#5332
20060148754
2006-07-06

Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance

#5333
20060148735
2006-07-06

Methods for treating, preventing, or reducing cardiac disorders using fadd inhibitors

#5334
20060148712
2006-07-06

Monocyte chemoattractant activity of galectin-3

#5335
20060148697
2006-07-06

Methods for treating and preventing brain cancers

#5336
20060148681
2006-07-06

Method for treating tumor and/or preventing tumor metastasis and relapse

#5337
20060148086
2006-07-06

Vault and vault-like carrier molecules

#5338
20060148001
2006-07-06

Compositions and methods for treating female fertility

#5339
20060147442
2006-07-06

Biocides

#5340
20060147395
2006-07-06

Protein formulation

#5341
20060142233
2006-06-29

Gene expression and genetic changes implicated in alcoholism

#5342
20060142220
2006-06-29

Protein modification

#5343
20060142194
2006-06-29

Methods and compounds for treating brain amyloidosis

#5344
20060141602
2006-06-29

Packaging of positive-strand RNA virus replicon particles

#5345
20060140970
2006-06-29

Proteic binding partners of TCTP and methods of modulating tumor reversion or cell apoptosis

#5346
20060140935
2006-06-29

Platlet glycoprotein Ib alpha fusion polypeptides and methods of use thereof

#5347
20060135747
2006-06-22

Pancreatic polypeptide family motifs, polypeptides and methods comprising the same

#5348
20060135412
2006-06-22

Methods for the treatment of alzheimers disease and compositions therefore

#5349
20060135403
2006-06-22

Therapeutic formulations for the treatment of beta-amyloid related diseases

#5350
20060134119
2006-06-22

Drugs containing galectin 9

#5351
20060134117
2006-06-22

Preventives/remedies for cancer

#5352
20060134076
2006-06-22

Three dimensional bioengineered smooth muscle tissue and sphincters and methods therefor

#5353
20060127895
2006-06-15

Use of c-Jun or c-Jun activating agents such as UV or c-Jun N-terminal kinases (JNKs) for treating cancer

#5354
20060127492
2006-06-15

Sustained improver of muscular fatigue

#5355
20060127397
2006-06-15

RAG polypeptides, nucleic acids, and their use

#5356
20060127312
2006-06-15

Notch signaling in long-term memory formation

#5357
20060122131
2006-06-08

Methods for blocking adipocyte differentiation and triglyceride accumulation with transcription factor dp-1 inhibitors

#5358
20060122110
2006-06-08

Nogo, caspr, f3 nb-3 useful in the treatment of injury and disease to the central nervous system

#5359
20060122107
2006-06-08

Method of modulating cellular activity and molecules for use therein

#5360
20060122102
2006-06-08

Methods and preparations for curing critically ill patients

#5361
20060121566
2006-06-08

Stem cell expansion factor blocking gene limiting hox-induced expansion and method using such factor

#5362
20060121485
2006-06-08

Compounds and methods for detection of carcinomas and their precursor lesions

#5363
20060121046
2006-06-08

Compositions and methods for WT1 specific immunotherapy

#5364
20060121029
2006-06-08

Method and composition for regulating the activity of regulatory t cells

#5365
20060120995
2006-06-08

Neoadjuvant genetic compositions and methods

#5366
20060115839
2006-06-01

Methods of identifying an agent that modulates an interaction between 53BP1 and histone H3, and uses thereof

#5367
20060115480
2006-06-01

Disease treatment via antimicrobial peptide inhibitors

#5368
20060111314
2006-05-25

Method for treating or preventing metastasis of colorectal cancers

#5369
20060111313
2006-05-25

Nell-1 enhanced bone mineralization

#5370
20060111301
2006-05-25

Methods for preventing and treating Alzheimer's disease

#5371
20060111292
2006-05-25

Treatment of type I diabetes

#5372
20060111285
2006-05-25

Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells

#5373
20060111283
2006-05-25

Prevention therapy and prognosis/monitoring in sepsis and septic shock

#5374
20060110398
2006-05-25

DAP-10 and uses thereof

#5375
20060110376
2006-05-25

MDA-7 and free radicals in the treatment of cancer

#5376
20060105952
2006-05-18

Modified annexin proteins and methods for their use in organ transplantation

#5377
20060100143
2006-05-11

Polypeptide

#5378
20060100142
2006-05-11

Use of uk114 in the treatment of leishmaniasis

#5379
20060100131
2006-05-11

Modulation of stem cell differentiation by modulation of caspase-3 activity

#5380
20060099277
2006-05-11

Protein and fruit juice product

#5381
20060099194
2006-05-11

Clusterin-mediated inhibition of apoptosis via stromal bone marrow cell delivery to a cardiac site

#5382
20060099183
2006-05-11

Use of recombinant adeno-associated virus vector (rAAV) for the prevention of smooth muscle cell proliferation in a vascular graft

#5383
20060099150
2006-05-11

Compositions and methods for the transport of biologically active agents across cellular barriers

#5384
20060094679
2006-05-04

Method of preventing or treating liver disease

#5385
20060094653
2006-05-04

Pancreatic polypeptide family motifs and polypeptides comprising the same

#5386
20060093614
2006-05-04

Platelet glycoprotein Ib alpha fusion polypeptides and methods of use thereof

#5387
20060093612
2006-05-04

Use of heat shock proteins to enhance efficacy of antibody therapeutics

#5388
20060093608
2006-05-04

Low molecular weight protein tyrosine phosphatase (LMW-PTP) as a diagnostic and therapeutic target

#5389
20060093553
2006-05-04

Cd26-based therapies for cancers and immune disease

#5390
20060089297
2006-04-27

Sperm specific lysozyme-like proteins

#5391
20060088846
2006-04-27

Methods to identify compounds useful for the treatment of proliferative and differentiative disorders

#5392
20060088600
2006-04-27

Treatment for dry eye syndrome

#5393
20060088524
2006-04-27

Tissue factor compositions and methods

#5394
20060084603
2006-04-20

IGF-BP3-related methods for inhibiting tumor growth

#5395
20060079458
2006-04-13

Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

#5396
20060079452
2006-04-13

Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes

#5397
20060079451
2006-04-13

Heparin-binding proteins modified with sugar chains, method of producing the same and pharmaceutical compositions containing same

#5398
20060079449
2006-04-13

Inhibition of Smad3 to prevent fibrosis and improve wound healing

#5399
20060079447
2006-04-13

Stabilized A-beta protofibrillar aggregates

#5400
20060079446
2006-04-13

Methods and compositions for treating hypercholesterolemia